On Sept. 9, 2021, the National Institutes of Health (NIH) announced that it was providing approximately $185 million…
On Sept. 9, 2021, the University of Pennsylvania announced that the Breakthrough Prize in Life Sciences was awarded…
On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
On Sept. 8, 2021, National Resilience, a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem,…
On Sept. 7, 2021, Takeda Pharmaceutical announced the Government of Japan’s Ministry of Health, Labour and Welfare purchase…
On Sept. 6, 2021, Pfizer and BioNTech announced that they submitted a variation to the European Medicines Agency…
On Sept. 3, 2021, The Centers for Disease Control and Prevention (CDC) awarded more than $116 million in…
On Sept. 1, 2021, Novartis announced a commercial agreement with the NHS in England as part of a…
On Sept. 1, 2021, Rigel Pharma announced the publication of results from a Phase 2 clinical trial evaluating…
On Sept. 1, 2021, Quidel announced it will make Quidel’s non-prescription QuickVue® At-Home OTC COVID-19 Test available to…
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEﾮ as a…
On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…
On Aug. 30, 2021, the Mayo Clinic reported that in an observational study the combination of casirivimab and…
On Aug. 27, 2021, researchers at University of British Columbia’s (UBC) faculty of medicine and BC Cancer Research…
On Aug. 27, 2021, the National Institutes of Health announced that it had begun a clinical trial to…
On Aug. 27, 2021, National Aeronautics and Space Administration (NASA) Space station astronauts successfully demonstrated DNA repair in…
On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study found that blood serum…
On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…
On Aug. 25, 2021, Anixa Biosciences announced that a genomic variant analysis indicateed that its potential compounds may…
On Aug. 20, 2021, Regeneron announced that the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency had…
On Aug. 19, 2021, Oregon Health & Science University (OHSU) announced that it was part of a randomized,…
On Aug. 19, 2021, the University of Oxford reported that obtaining two vaccine doses remained the most effective…
On Aug. 18, 2021, the final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)…
On Aug. 17, 2021, researchers reported the delta variant of the virus that causes COVID-19 was not particularly…
On Aug. 13, 2021, Merck announced that the U.S. Food and Drug Administration (FDA) had approved WELIREG, an…
On Aug. 13, 2021, Rigel Pharma announced that the U.S. Food and Drug Administration (FDA) had informed the…
On Aug. 12, 2021, Innovation Pharma released information regarding the status of its randomized, double-blind, placebo-controlled Phase 2…
On Aug. 11, 2021, the World Health Organization (WHO) announced the next phase in its Solidarity trial that…
On Aug. 5, 2021, an international team of researchers announced that a mutation in a single gene appeared…
On Aug. 4, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) had published positive detailed…